Episodes 451-465 of 747
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
Project Oncology®FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer
Medical Breakthroughs from Penn MedicineCAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer
Rethinking Nicotine: The Campaign to Break the World's Tobacco Habit
Primary Care TodayRethinking Nicotine: The Campaign to Break the World's Tobacco Habit
FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease
FDA Drug Information UpdatesFDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease
Pancreatic Cancer: The Hunt to Catch a Silent Killer
Project Oncology®Pancreatic Cancer: The Hunt to Catch a Silent Killer
- advertisement
FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
Project Oncology®FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer
Project Oncology®FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer
The CAM Guide to Cancer: An Integrative Approach to Prevention, Treatment, and Healing
NutritionEdgeThe CAM Guide to Cancer: An Integrative Approach to Prevention, Treatment, and Healing
Knowing your Patient's Melanoma Risk Factors
Everyday Family MedicineKnowing your Patient's Melanoma Risk Factors
Linking p53 Variation to Breast Cancer Risk in African American Women
Project Oncology®Linking p53 Variation to Breast Cancer Risk in African American Women
- advertisement
FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval
Project Oncology®FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval
Pancreatic Cancer: Associated Signs, Symptoms, Risk Factors and Treatment Approaches
Project Oncology®Pancreatic Cancer: Associated Signs, Symptoms, Risk Factors and Treatment Approaches
The Financial Burden of Cancer: Report from the American Cancer Society
Primary Care TodayThe Financial Burden of Cancer: Report from the American Cancer Society
